Thomas Strong is currently the Market Access Team Lead for Vaccines and Immune Therapies at AstraZeneca, a position held since 2023. From 2018 to 2022, Thomas served as the Interim Associate Director for Managed Access at NICE, where they led a multidisciplinary team on various managed access topics. Previously, Thomas worked as an HTA Adviser and Technical Analyst at NICE, focusing on health technology assessments and the development of real-world evidence. Thomas began their academic journey at the University of Bristol, earning a Bachelor of Science in Biochemistry, followed by a Master of Science in Molecular Neuroscience.
This person is not in the org chart
This person is not in any teams
This person is not in any offices